secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elanco Animal Health Inc (ELAN)
CIK:        0001739104
Form:       8-K
Filed at:   2023-01-09T23:59:59+00:00
Accession:  0001104659-23-002071
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Elanco discloses FDA submission for JAK inhibitor at JPM conference
-------------------------------------------------------------------

- Company notes Q4 2022 submission to FDA for its JAK inhibitor.
- Presentation made at 41st Annual J.P. Morgan Healthcare Conference on Jan 10, 2023.
- No financial results or guidance changes provided in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1739104/000110465923002071/0001104659-23-002071-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1739104/000110465923002071/tm232554d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-002071

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer